CHC – The Cancer & Hematology Centers



What kind of cancer is this for? Diffuse Large B-Cell lymphoma.

Phase: III

Who is this trial for? Men and women who are younger than or equal to 75  years old with lymphoma that has never been treated before. 

What biomarkers are involved? None

What is National Clinical Trial #? NCT04529772

Brief summary of trial: This trial is looking to see if the study drug (acalabrutinib) added to RCHOP (chemo plan) works better than RCHOP and a harmless drug.

Need to know: You must be younger or equal to 75 years old and your cancer cell type must be non-germinal center B-cell lymphoma.

Where is this trial available? The Cancer & Hematology Centers

For more information, please call 616-975-3065 or email